The Globe and Mail’s Regenerative Medicine webcast, presented by Bayer.

Stem cells hold the potential to create new and innovative treatments and therapies for illnesses such as Parkinson’s, cardiovascular disease and cancer. Researchers in Canada are working on stem cell advances to test new therapies, and to grow and repair tissues, organs and damaged cells, paving the way for a future of regenerative medicine and disease prevention. This webcast will cover what these advances mean for health care, along with risks, opportunities and considerations to take into account.

Panel Discussion
Gordon Keller, Co-Founder, BlueRock Therapeutics

Cate Murray, Executive Director and COO, Stem Cell Network

Karen Lee, CEO, Parkinson Canada

Jonathan Kimmelman, James McGill Professor of Biomedical Ethics, McGill University

André Picard, Health Reporter and Columnist, The Globe and Mail